InnoCan Pharma is a pharmaceutical company specializing in developing novel therapeutics that harness the unique healing properties of Cannabinoids to improve quality of life.
OUR ADVANTAGES
Led by a highly-experienced team with a proven track record of success, InnoCan will leverage Israel’s worldleading medical cannabis research community to develop powerful, Cannabinoid-combined, patent-pending formulas. Our outstanding products will be clinically validated by undertaking Post Marketing Surveillance (PMS) studies and combine smart delivery systems to enhance the potency and efficacy of current products for better results.
EXPECTED EARLY REVENUES:
InnoCan expects to generate early revenues ($30 million in 5 years) from the multi-billion dollar Over The Counter (OTC) market by leveraging the rapid FDA OTC drug monograph process or similar regulatory pathways in Europe and Canada. These regulatory pathways enable InnoCan, in a very short time, to bring to market outstanding new products that combine the huge therapeutic potential of Cannabinoid complex/hemp oil added “excipients” to existing approved OTC drugs.
TECHNOLOGY: POWERFUL, PATENT PENDING FORMULAS WITH SMART DELIVERY SYSTEMS
InnoCan's products will be highly differentiated within the market through the powerful synergistic effect of the Cannabis-complex Hemp Oil with the active ingredients, combined with our on-demand release delivery system providing improved patient efficacy and compliance.
FIRST-LINE PRODUCTS: A LEAP-FORWARD IN DERMATOLOGY TREATMENT DESIGN
The companies first products will initially target the multi-billion dollars markets of psoriasis and localized pain , where research shows topical cannabinoid-combined treatments are highly effective, followed by oral hygiene, eczema/ itching, skin support after chemotherapy and women's health.
To join the investment opportunity with InnoCan, please contact Iris Bincovich at
IrisB@InnocanPharma.com.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 10 Hamenofim St., Herzliya,israel 4672561,israel
- Phone
- +972.54.471.1171
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- innocanpharma.com
- Keywords
- Cannabinoid-integrated pharmaceuticals, Cannabinoids, Pharmaceuticals, Cannabis, Hemp oil, OTC products, Psoriasis, Pain, Topical treatments, Topical Analgesics, Eczema & itching, Oral Hygiene, Women's Health, Healthcare.
- HQ
- Herzliya, Israel
Innocan Pharma Questions
Innocan Pharma's helpline number is +972.54.471.1171
Innocan Pharma's website is innocanpharma.com
Innocan Pharma's LinkedIn profile is https://il.linkedin.com/company/innocanpharma
Innocan Pharma has
15 employees.
View email and phone details for 15
employees at Innocan Pharma.
Innocan Pharma's industry is
Pharmaceutical Manufacturing
Innocan Pharma's top competitors are
Ir-Med Inc. (Otcqb:irme),
Bi Sky Global Ltd.,
Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90),
Simplivia Healthcare Ltd.,
Concept Consulting,
Entera Bio Ltd.,
Virucure Therapeutics,
Innocan,
G-Med,
Icecure Medical.
Innocan Pharma's support email address is info@innocanpharma.com
Innocan Pharma's categories are Pharmaceutical Manufacturing
Innocan Pharma's founding year is 2017
